Several studies have reported the FOXP3 expression increase in tumor cells, and in some cases with tumor suppressor activity, as in ovarian, prostate, and breast cancer [29,32,56], but also as an oncoprotein, as in gastric, bladder, lung, and cervical cancer, among others [37,38,40,57]. Here, FOXP3 is linked to cervical cancer.